Bortezomib in combination with thalidomide and dexamethasone--a successful treatment regimen in refractory extramedullary multiple myeloma

Ann Hematol. 2008 Mar;87(3):253-4. doi: 10.1007/s00277-007-0401-8. Epub 2007 Oct 23.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Boronic Acids / administration & dosage
  • Bortezomib
  • Dexamethasone / administration & dosage
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Multiple Myeloma / diagnostic imaging
  • Multiple Myeloma / therapy*
  • Peripheral Blood Stem Cell Transplantation*
  • Plasmacytoma / diagnostic imaging
  • Plasmacytoma / therapy*
  • Pyrazines / administration & dosage
  • Radiography
  • Remission Induction
  • Spinal Neoplasms / diagnostic imaging
  • Spinal Neoplasms / therapy*
  • Thalidomide / administration & dosage
  • Transplantation, Autologous

Substances

  • Boronic Acids
  • Pyrazines
  • Thalidomide
  • Bortezomib
  • Dexamethasone